XML 33 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities:    
Net loss from continuing operations $ (4,412,050) $ (2,075,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 51,507 51,484
Loss on sale of equipment 73,750 36,627
Loss on debt settlements 131,944
Amortization of original issue discount   22,500
Amortization of debt discount 515,814 438,032
Amortization of debt offering costs   20,000
Loss on impairment of goodwill 1,440,961  
Loss on investment in joint venture 250,000  
Derivative interest expense 66,980
Change in fair value of embedded derivative liability 442,957 141,756
Stock issued for services - related party 159,930
Stock issued for services 407,000 465,424
Change in:    
Accounts receivable 34,853 17,024
Other receivable 7,323
Inventory 2,360 4,641
Prepaid expense (4,452) 1,697
Accounts payable and accrued expenses 33,236 15,763
Deferred rent (2,274) (1,265)
Accrued compensation - officers (489)
Costs and estimated earnings in excess of billings (20,155) 224
Net cash used in operating activities (1,019,729) (662,170)
Cash flows from investing activities:    
Proceeds from the sale of equipment 10,800 10,000
Investment in joint venture (250,000)  
Purchase of equipment and software (550) (12,294)
Net cash (used in) investing activities (239,750) (2,294)
Cash flows from financing activities:    
Repayments of note payable (6,787)
Proceeds from convertible notes payable, less offering costs and OID costs paid 500,000 675,000
Repayment of convertible note (175,000) (208,223)
Settlement of demand note payable, less OID costs paid (225,500)
Issuance of preferred stock for cash 300,000 125,000
Issuance of common stock for cash 824,000 50,000
Net cash provided by financing activities 1,216,713 641,777
Decrease cash and cash equivalents (42,766) (22,687)
Cash and cash equivalents at beginning of period 78,219 100,906
Cash and cash equivalents at end of period 35,453 78,219
Cash paid during the period for:    
Interest 2,469 3,481
Income taxes
Supplemental disclosure of non-cash investing and financing activities:    
Beneficial conversion feature 120,333 333,900
Shares issued for debt issuance costs 143,500
Shares issued on conversion of convertible debt 203,351
Unused commitment fee 50,000
Settlement of convertible note into common shares $ 100,000
Partial conversion of convertible note into common shares 75,000  
Conversion of preferred shares into common shares $ 2,500
Stock issued for the Alamo CBD acquisition 1,440,961
Voluntary return of stock by related party $ 2,500